315 results on '"McNitt A"'
Search Results
2. Differences in mode of death between men and women receiving implantable cardioverter-defibrillators or cardiac resynchronization therapy in the MADIT trials
3. Sex hormones and repolarization dynamics during the menstrual cycle in women with congenital long QT syndrome
4. Use of oral contraceptives in women with congenital long QT syndrome
5. Utility of cardiovascular implantable electronic device–derived patient activity to predict clinical outcomes
6. Cardiac resynchronization therapy and ventricular tachyarrhythmia burden
7. Sex differences in arrhythmic burden with the wearable cardioverter-defibrillator
8. Reassessing the role of antitachycardia pacing in fast ventricular arrhythmias in primary prevention implantable cardioverter-defibrillator recipients: Results from MADIT-RIT
9. Risk of arrhythmic events after alcohol septal ablation for hypertrophic cardiomyopathy using continuous implantable cardiac monitoring
10. Predictors and outcomes of atrial tachyarrhythmia among patients with implantable defibrillators
11. Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-Defibrillator
12. PO-03-216 HYBRID VT ABLATION-SUBCUTANEOUS ICD MANAGEMENT STRATEGY FOR SECONDARY PREVENTION OF SUDDEN CARDIAC DEATH: THE VTABL-SICD TRIAL
13. Predictive value of device-derived activity level for short-term outcomes in MADIT-CRT
14. Bipolar left ventricular pacing is associated with significant reduction in heart failure or death in CRT-D patients with LBBB
15. Predictors and clinical relevance of ventricular tachyarrhythmias in ambulatory patients with a continuous flow left ventricular assist device
16. Relationship between age and inappropriate implantable cardioverter-defibrillator therapy in MADIT-RIT (Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy)
17. Brain natriuretic peptide and the risk of ventricular tachyarrhythmias in mildly symptomatic heart failure patients enrolled in MADIT-CRT
18. Stop-codon and C-terminal nonsense mutations are associated with a lower risk of cardiac events in patients with long QT syndrome type 1
19. PO-04-226 RISK OF VENTRICULAR RECURRENT TACHYARRHYTHMIA IN PATIENTS RECEIVING PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
20. MP-453089-1 DIGOXIN AND RISK OF VENTRICULAR TACHYARRHYTHMIA AND DEATH IN ICD RECIPIENTS
21. CE-452779-3 RANDOMIZED PLACEBO-CONTROLLED TRIAL OF FLECAINIDE IN PATIENTS WITH ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY
22. PO-05-053 RACIAL AND SEX-DIFFERENCES IN VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH NON-ISCHEMIC CARDIOMYOPATHY WITH IMPLANTED DEFIBRILLATORS
23. PO-05-079 SMOKING AND THE RISK OF VENTRICULAR TACHYARRHYTHMIAS AMONG IMPLANTABLE CARDIOVERTER DEFIBRILLATOR RECIPIENTS FOR PRIMARY PREVENTION OF SUDDEN CARDIAC DEATH
24. LB-456090-1 CONTEMPORARY OUTCOMES OF NON-ISCHEMIC CARDIOMYOPATHY PATIENTS WITH AN IMPLANTED DEFIBRILLATOR OR CARDIAC RESYNCHRONIZATION THERAPY (BIO-LIBRA)
25. CI-452767-2 LEFT-TO-RIGHT ATRIOVENTRICULAR ACTIVATION DELAY, A NOVEL MEASURE OF AV-CONDUCTION, PREDICTS BENEFIT VERSUS HARM OF CRT IN NON-LBBB PATIENTS
26. Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial
27. Characterization and predictors of first and subsequent inappropriate ICD therapy by heart rate ranges: Result of the MADIT-RIT efficacy analysis
28. LB-456090-1 CONTEMPORARY OUTCOMES OF NON-ISCHEMIC CARDIOMYOPATHY PATIENTS WITH AN IMPLANTED DEFIBRILLATOR OR CARDIAC RESYNCHRONIZATION THERAPY (BIO-LIBRA)
29. PO-05-079 SMOKING AND THE RISK OF VENTRICULAR TACHYARRHYTHMIAS AMONG IMPLANTABLE CARDIOVERTER DEFIBRILLATOR RECIPIENTS FOR PRIMARY PREVENTION OF SUDDEN CARDIAC DEATH
30. MP-453089-1 DIGOXIN AND RISK OF VENTRICULAR TACHYARRHYTHMIA AND DEATH IN ICD RECIPIENTS
31. CI-452767-2 LEFT-TO-RIGHT ATRIOVENTRICULAR ACTIVATION DELAY, A NOVEL MEASURE OF AV-CONDUCTION, PREDICTS BENEFIT VERSUS HARM OF CRT IN NON-LBBB PATIENTS
32. Atrioventricular delay programming and the benefit of cardiac resynchronization therapy in MADIT-CRT
33. Clinical significance of ventricular tachyarrhythmias in patients treated with CRT-D
34. Prognostic implications of mutation-specific QTc standard deviation in congenital long QT syndrome
35. Effects of cardiac resynchronization therapy on left ventricular mass and wall thickness in mild heart failure patients in MADIT-CRT
36. Differing effects of cardiac resynchronization therapy on long-term mortality in patient subgroups of MADIT-CRT defined by baseline conduction and 1-year post-treatment left ventricular remodeling
37. Risk of life-threatening cardiac events among patients with long QT syndrome and multiple mutations
38. Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT)
39. Baseline functional capacity and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT
40. Combined assessment of sex- and mutation-specific information for risk stratification in type 1 long QT syndrome
41. Myocardial performance is reduced immediately prior to ventricular ectopy
42. Trigger-specific ion-channel mechanisms, risk factors, and response to therapy in type 1 long QT syndrome
43. PO-05-053 RACIAL AND SEX-DIFFERENCES IN VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH NON-ISCHEMIC CARDIOMYOPATHY WITH IMPLANTED DEFIBRILLATORS
44. CE-452779-3 RANDOMIZED PLACEBO-CONTROLLED TRIAL OF FLECAINIDE IN PATIENTS WITH ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY
45. PO-04-226 RISK OF VENTRICULAR RECURRENT TACHYARRHYTHMIA IN PATIENTS RECEIVING PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
46. Long-term implications of cumulative right ventricular pacing among patients with an implantable cardioverter-defibrillator
47. Mutation and gender-specific risk in type 2 long QT syndrome: Implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome
48. Genotype-specific QT correction for heart rate and the risk of life-threatening cardiac events in adolescents with congenital long-QT syndrome
49. T-wave morphology abnormalities in benign, potent, and arrhythmogenic I kr inhibition
50. The incidence and prognostic significance of new-onset atrial fibrillation in patients with acute myocardial infarction and left ventricular systolic dysfunction: A CARISMA substudy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.